FDA approves Keytruda as adjuvant treatment for kidney cancer
November 18, 2021 at 19:04 PM EST
The cancer immunotherapy drug Keytruda, was approved Thursday by the FDA
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |